Viability of Myocardium and Influences on Outcomes Following Revascularization or Medical Therapy

Interview with Divaka Perera, MA, MD, author of Viability and Outcomes With Revascularization or Medical Therapy in Ischemic Ventricular Dysfunction: A Prespecified Secondary Analysis of the REVIVED-BCIS2 Trial, and Julio A. Panza, MD, author of Assessment of Myocardial Viability in Ischemic Cardiomyopathy—Scarred by the Data but Still Alive. Hosted by James E. Udelson, MD.

Related Content:

• Viability and Outcomes With Revascularization or Medical Therapy in Ischemic Ventricular Dysfunction
• Assessment of Myocardial Viability in Ischemic Cardiomyopathy—Scarred by the Data but Still Alive